Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Kiniksa Pharmaceuticals International, p - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
KNSA
Nasdaq
2830
www.kiniksa.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Kiniksa Pharmaceuticals International, p
Grab These 4 Stocks With Solid Net Profit Margins to Maximize Returns
- Jun 29th, 2026 6:18 am
Here's Why You Should Add Kiniksa Stock to Your Portfolio Now
- Jun 26th, 2026 8:34 am
Biotech Kiniksa Pushes Toward A Buy Zone With Blockbuster Drug Sales In View
- Jun 23rd, 2026 1:11 pm
Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going
- Jun 19th, 2026 6:55 am
Kiniksa Pharmaceuticals International, plc (KNSA) Upgraded to Strong Buy: Here's What You Should Know
- Jun 16th, 2026 10:00 am
NTLA Posts Strong Additional Phase III Data From HAE Study, Stock Up
- Jun 16th, 2026 8:17 am
ALKS' Sleep Disorder Drug Gets Orphan Drug Tags in the U.S. & Europe
- Jun 16th, 2026 8:15 am
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
- May 29th, 2026 2:01 pm
High Growth Tech Stocks in the US for May 2026
- May 26th, 2026 11:38 am
Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
- May 23rd, 2026 5:50 am
We Think Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) Profit Is Only A Baseline For What They Can Achieve
- May 8th, 2026 8:59 am
Kiniksa Pharmaceuticals International (KNSA) Is Up 29.2% After Raising 2026 Net Product Revenue Guidance
- May 1st, 2026 7:18 pm
Kiniksa Pharmaceuticals International (KNSA) Announces Q1 2026 Financial Results
- May 1st, 2026 1:58 am
Kiniksa Pharmaceuticals International PLC (KNSA) Q1 2026 Earnings Call Highlights: Robust ...
- Apr 29th, 2026 1:05 am
Kiniksa Pharmaceuticals International Q1 Earnings Call Highlights
- Apr 28th, 2026 9:29 am
Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue Estimates
- Apr 28th, 2026 6:45 am
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
- Apr 28th, 2026 5:30 am
High Growth Tech Stocks To Watch In The US This April 2026
- Apr 27th, 2026 5:38 am
Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026
- Apr 23rd, 2026 2:01 pm
Kiniksa’s Heart’s Home Campaign Puts ARCALYST Growth Prospects In Focus
- Apr 8th, 2026 6:19 pm
Scroll